New Treatment Strategies

Pictured: Nai-Kong Cheung Nai-Kong Cheung, Head of the Neuroblastoma Program, is one of many researchers studying better ways to treat pediatric cancers and achieve long-term survival.

In addition to delivering world-class care, the pediatric cancer experts at Memorial Sloan Kettering participate in groundbreaking laboratory and clinical research. As both oncologists and scientists, we are dedicated to developing safer and more-effective therapies to control and cure childhood cancers as well as to allow our patients to return to their daily activities as quickly as possible. We are also committed to minimizing any short- and long-term effects that your child may experience during cancer treatment.

Learn more about our innovative treatment strategies, including clinical trials, new drug combinations, antibody-based therapy, radiolabeled antibody therapy, and cell-based treatment for many types of pediatric cancers.